Cited by 296Ovarian function and disordersDiabetes, Cardiovascular Risks, and LipoproteinsReproductive Biology and Fertility

The DOI matches its Crossref record; 156 of the 162 references it cites were found in a registry or an index.

Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility

Open access
Morley, Lara C, Tang, Thomas, Yasmin, Ephia, Norman, Robert J, Balen, Adam H·2017·Cochrane Database of Systematic Reviews

Abstract

This is a repository copy of Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/14651858.cd003053.pub6

Cites

156 of 156 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

3 retracted

Show all 162 references

Research works printed but not linked: 15

  1. El-Biely, 2001, The use of metformin to augment the induction of ovulation in obese infertile patients with polycystic ovary syndrome, Middle East Fertility Society Journal, 6, 43
  2. Machado, 2012, Evaluation of the use of metformin for ovulation in patients with PCOS resistant to isolated use of clomiphene citrate, Brazilian Journal Assisted Reproduction, 16, 27
  3. Casimirri, 1997, Metformin improves insulin, body fat distribution, and androgens in obese women with and without the polycystic ovary syndrome, International Journal of Obesity, 21 Suppl 2, 61
  4. Chaudhry, 2016, Comparison between pioglitazone and metformin in terms of efficacy in patients with polycystic ovarian syndrome, Pakistan Journal of Medical and Health Sciences, 10, 574
  5. Morin-Papunen, 2010, Metformin improves pregnancy and live birth rates in women with polycystic ovary syndrome - a multicentre placebo-controlled randomised trial, 26th Annual Meeting of the European Society of Human Reproduction and Embryology, ESHRE Rome Italy, 25, i67
  6. Ramzy, 2003, The use of metformin in overweight and lean infertile patients with polycystic ovarian syndrome: a randomised controlled trial, Middle East Fertility Society Journal, 8, 143
  7. Santonocito, 2009, Comparison between clomiphene citrate and metformin for induction of ovulatory cycles in infertile nonobese women with polycystic ovary syndrome, Giornale Italiano di Ostetricia e Ginecologia, 31, 455
  8. Deeks JJ Higgins JPT Altman DG (editors) Chapter 9: Analysing data and undertaking meta-analyses. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org
  9. Higgins JPT Altman DG Sterne JAC (editors) Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org
  10. Lefebvre C Manheimer E Glanville J Chapter 6: Searching for studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org
  11. Rautio, 2006, Endocrine and metabolic effects of rosiglitazone in overweight women with PCOS: a randomized placebo-controlled study, Human Reproduction, 21, 1400, 10.1093/humrep/dei505 · DOI
  12. Rautio, 2007, Rosiglitazone treatment alleviates inflammation and improves liver function in overweight women with polycystic ovary syndrome: a randomized placebo-controlled study, Fertility and Sterility, 87, 202, 10.1016/j.fertnstert.2006.05.061 · DOI
  13. Nordic Cochrane Centre, The Cochrane Collaboration Review Manager 5 (RevMan 5) 2014
  14. Schünemann HJ Oxman AD Higgins JPT Vist GE Glasziou P Guyatt GH Chapter 11: Presenting results and ‘Summary of findings' tables. In: Higgins JPT, Green S (editors), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org
  15. Sterne JAC Egger M Moher D (editors) Chapter 10: Addressing reporting biases. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Intervention . Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org

Cited by

Sorted by citations

Items 201–295 of 295

Metadata

Authors
Morley, L. C., Tang, T., Yasmin, E., Norman, R. J., & Balen, A. H.
Affiliations
  • Leeds General Infirmary (GB)
  • Royal Jubilee Maternity Services (GB)
  • University College Hospital (GB)
  • The University of Adelaide (AU)
  • Seacroft Hospital (GB)
Venue
Cochrane Database of Systematic Reviews
Publisher
Wiley
Published
2017-11-28
Volume
2018
Issue
2
ISSN
  • 1361-6137 (ISSN-L)
  • 1465-1858
OpenAlex
W2982638573
Cited by
296
References
162
Citations by year
2026: 14 · 2025: 34 · 2024: 31 · 2023: 43 · 2022: 45 · 2021: 39 · 2020: 33 · 2019: 28 · 2018: 18 · 2017: 4
FWCI
3.70
Type
journal article
Language
en
Open access
Locations
  • Cochrane Database of Systematic Reviews (publishedVersion)
  • White Rose Research Online (University of Leeds, The University of Sheffield, University of York) (acceptedVersion)
Funders
Medical Research Council (MR/P002099/1)
Topics
  • Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Health Sciences › Medicine › Reproductive Medicine › Reproductive Biology and Fertility
Keywords
metformin, rosiglitazone, pioglitazone, D-chiro-inositol, polycystic ovary syndrome, subfertility, infertility treatment, ovulation induction

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review